Open-to-Accrual Therapeutic Trials


Head and Neck Cancer

Protocol ID

Official Title

PI Name

Lead CRC

Disease Site

Phase

RTOG-1216 ClinicalTrials.gov: NCT01810913

Randomized Phase I/III Trials of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

S. Ghamande

Inquiries

Head and Neck Squamous Cell Cancer

II/III

IDR-OM-02 ClinicalTrials.gov:  NCT03237325

A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

A. Guddati

Kelly Adams

Head and Neck Squamous Cell Cancer

III